Skip to main content
. 2020 Sep 1;12(9):2474. doi: 10.3390/cancers12092474

Figure 4.

Figure 4

(A) Overall frequency of TORS use, (B) relative proportion of adjuvant therapy over time, (C) use of adjuvant therapy by Tumor (T) and Node (N) stage.